全球器官晶片市场研究报告 - 2023 年至 2030 年产业分析、规模、份额、成长、趋势与预测

全球器官晶片市场需求预计将从 2022 年的 88.45 万美元达到 2030 年近 1,049.83 万美元的市场规模，2023-2030 年研究期间CAGR为 36.24%。

器官晶片（OOC）是一种能够模仿人体器官结构和功能的微流控细胞培养装置。它的目的是复製特定器官的生理和机械方面，以提供比传统细胞培养方法更准确和动态的人类生物学表征。每个设备都旨在模拟特定器官或组织的微环境和细胞相互作用。

市场动态：

由于其在生物医学研究和药物开发方面的变革潜力，器官晶片市场正在迅速扩大。该技术透过提供更多与人类相关的器官和组织表示来解决传统模型的局限性。它为动物测试提供了一种人道的替代方案，符合日益增加的道德问题和监管压力。 OOC 平台准确模仿人类生物学的能力对药物开发具有深远的影响，增强了对药物功效和安全性的预测。此外，这些模型透过允许研究个体对治疗的反应来支持个人化医疗的进步。该市场进一步受到政府、研究机构和製药公司投资的推动，促进了合作和技术进步。微加工技术的不断改进有助于提高 OOC 系统的可扩展性和复杂性。随着慢性病的增加，监管机构对 OOC 模型的验证强调了它们彻底改变医疗保健和研究实践的潜力。随着合作关係的蓬勃发展和接受度的提高，器官晶片技术有望在重塑生物医学研究和治疗开发方面发挥关键作用。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球晶片器官市场的各个细分市场进行了包容性评估。晶片上器官产业的成长和趋势为这项研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的晶片器官市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。器官晶片市场的主要参与者包括 Emulate, Inc.、MIMETAS BV、Valo Health、Nortis, Inc.、AxoSim、BICO - THE BIO CONVERGENCE COMPANY、CN Bio Innovations Ltd、SynVivo, Inc.、The Charles Stark Draper实验室有限公司，AlveoliX AG。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：晶片上的器官 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按产品和服务分類的市场吸引力分析
  • 市场吸引力分析：依应用分类
  • 按最终用途分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球晶片器官市场分析：按产品和服务分类

• 按产品和服务分類的概述
• 历史和预测数据
• 按产品和服务分析
• 产品
• 仪器
• 器官晶片设备（晶片肝臟、晶片肺、晶片肠、晶片肾臟、晶片心臟等）
• 服务

第 6 章：全球晶片器官市场分析：依应用分类

• 概述：按应用
• 历史和预测数据
• 分析：按应用
• 药物发现
• 毒理学研究
• 其他的

第 7 章：全球晶片器官市场分析：依最终用途分类

• 按最终用途分類的概述
• 历史和预测数据
• 按最终用途分析
• 学术及研究机构
• 製药与生物技术公司
• 其他的

第 8 章：全球晶片器官市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 9 章：晶片器官公司的竞争格局

• 器官晶片市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 10 章：公司简介

• 公司股份分析
• 市场集中度
• Emulate Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• MIMETAS BV
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Valo Health
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Nortis Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• AxoSim
• 公司简介
• 公司收入
• 产品
• 最近的发展
• BICO - THE BIO CONVERGENCE COMPANY
• 公司简介
• 公司收入
• 产品
• 最近的发展
• CN Bio Innovations Ltd
• 公司简介
• 公司收入
• 产品
• 最近的发展
• SynVivo Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• The Charles Stark Draper Laboratory Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• AlveoliX AG
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for Organ On A Chip Market is presumed to reach the market size of nearly USD 1049.83 MN by 2030 from USD 88.45 MN in 2022 with a CAGR of 36.24% under the study period 2023 - 2030.

An Organ-on-a-Chip (OOC) is a microfluidic cell culture device that is able to mimic the structure and function of human organs. It aims to replicate the physiological and mechanical aspects of specific organs to provide a more accurate and dynamic representation of human biology compared to traditional cell culture methods. Each device is designed to simulate the microenvironment and cellular interactions of a particular organ or tissue.

MARKET DYNAMICS:

The organ-on-a-chip market is expanding rapidly due to its transformative potential in biomedical research and drug development. This technology addresses the limitations of traditional models by providing more human-relevant representations of organs and tissues. It offers a humane alternative to animal testing, aligning with increasing ethical concerns and regulatory pressures. The ability of OOC platforms to mimic human biology accurately has profound implications for drug development, enhancing predictions of drug efficacy and safety. Moreover, these models support the advancement of personalized medicine by allowing the study of individual responses to treatments. The market is further driven by investments from governments, research institutions, and pharmaceutical companies, fostering collaborations and technological advancements. Ongoing improvements in microfabrication technology contribute to the scalability and complexity of OOC systems. With rising chronic diseases, the validation of OOC models by regulatory authorities underscores their potential to revolutionize healthcare and research practices. As partnerships flourish and acceptance grows, Organ-on-a-Chip technology is poised to play a pivotal role in reshaping biomedical research and therapeutic development.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of organ on a chip. The growth and trends of organ on a chip industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the organ on a chip market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

• Products
• Instruments
• Organ-On-A-Chip Devices (Liver-On-A-Chip, Lung-On-A-Chip, Intestine-On-A-Chip, Kidney-On-A-Chip, Heart-On-A-Chip, Others)
• Services

By Application

• Drug Discovery
• Toxicology Research
• Others

By End-Use

• Academic And Research Institutes
• Pharmaceutical & Biotechnology Companies
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Organ On A Chip market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Organ On A Chip market include Emulate, Inc., MIMETAS B.V., Valo Health, Nortis, Inc., AxoSim, BICO - THE BIO CONVERGENCE COMPANY, CN Bio Innovations Ltd, SynVivo, Inc., The Charles Stark Draper Laboratory, Inc., AlveoliX AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . ORGAN ON A CHIP - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product & Service
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ORGAN ON A CHIP MARKET ANALYSIS BY PRODUCT & SERVICE

• 5.1 Overview by Product & Service
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Product & Service
• 5.4 Products Historic and Forecast Sales by Regions
• 5.5 Instruments Historic and Forecast Sales by Regions
• 5.6 Organ-on-a-Chip Devices (Liver-on-a-Chip, Lung-on-a-Chip, Intestine-on-a-Chip, Kidney-on-a-Chip, Heart-on-a-Chip, Others) Historic and Forecast Sales by Regions
• 5.7 Services Historic and Forecast Sales by Regions

6 . GLOBAL ORGAN ON A CHIP MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Drug Discovery Historic and Forecast Sales by Regions
• 6.5 Toxicology Research Historic and Forecast Sales by Regions
• 6.6 Others Historic and Forecast Sales by Regions

7 . GLOBAL ORGAN ON A CHIP MARKET ANALYSIS BY END-USE

• 7.1 Overview by End-use
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-use
• 7.4 Academic and Research Institutes Historic and Forecast Sales by Regions
• 7.5 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
• 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL ORGAN ON A CHIP MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ORGAN ON A CHIP COMPANIES

• 9.1. Organ On A Chip Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF ORGAN ON A CHIP INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Emulate Inc.
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. MIMETAS B.V.
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Valo Health
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Nortis Inc.
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. AxoSim
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. BICO - THE BIO CONVERGENCE COMPANY
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. CN Bio Innovations Ltd
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. SynVivo Inc.
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. The Charles Stark Draper Laboratory Inc.
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. AlveoliX AG
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product & Service (USD MN)
• Products Market Sales by Geography (USD MN)
• Instruments Market Sales by Geography (USD MN)
• Organ-on-a-Chip Devices (Liver-on-a-Chip, Lung-on-a-Chip, Intestine-on-a-Chip, Kidney-on-a-Chip, Heart-on-a-Chip, Others) Market Sales by Geography (USD MN)
• Services Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Drug Discovery Market Sales by Geography (USD MN)
• Toxicology Research Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End-use (USD MN)
• Academic and Research Institutes Market Sales by Geography (USD MN)
• Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Organ On A Chip Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Organ On A Chip Report
• Market Research Process
• Market Research Methodology
• Global Organ On A Chip Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product & Service
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by End-use
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product & Service (USD MN)
• Products Market Sales by Geography (USD MN)
• Instruments Market Sales by Geography (USD MN)
• Organ-on-a-Chip Devices (Liver-on-a-Chip, Lung-on-a-Chip, Intestine-on-a-Chip, Kidney-on-a-Chip, Heart-on-a-Chip, Others) Market Sales by Geography (USD MN)
• Services Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Drug Discovery Market Sales by Geography (USD MN)
• Toxicology Research Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-use (USD MN)
• Academic and Research Institutes Market Sales by Geography (USD MN)
• Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.